India reviews AstraZeneca side effects after concerns in Europe

New Delhi decided to conduct the review after several countries suspended rollout over blood clot fears even as the World Health Organization said there was no reason to stop using AstraZeneca's Covid-19 jab.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news